[Oncogenes and anti-oncogenes in breast cancer].
Recent developments in molecular oncology have permitted the definition of alterations in proto-oncogenes (ras, myc, neu and hst/int.2) and anti-oncogenes (Rb.1) in human breast carcinomas. Detection of these abnormalities could be of prognostic interest. However, this remains controversial.
Birnbaum
D
D
U.119, Marseille, France.
Gaudray
P
P
D001943:Breast Neoplasms / Q000235:genetics*; D011905:Genes, ras / Q000235:genetics; D006801:Humans; D009857:Oncogenes / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics; D016271:Proto-Oncogene Proteins c-myc; D011519:Proto-Oncogenes / Q000235:genetics; D018719:Erb-b2 Receptor Tyrosine Kinases
D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc; D018719:Erb-b2 Receptor Tyrosine Kinases
Les oncogènes et anti-oncogènes dans les cancers du sein.